PILA PHARMA AB
PILA PHARMA AB
Share · SE0015988274 · A3CT5N (XSTO)
Overview
No Price
Closing Price XSTO 30.10.2025: 2,20 SEK
30.10.2025 16:23
Current Prices from PILA PHARMA AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
PILA.ST
SEK
30.10.2025 16:23
2,20 SEK
0,010 SEK
+0,46 %
Share Float & Liquidity
Free Float 31,01 %
Shares Float 13,05 M
Shares Outstanding 42,08 M
Company Profile for PILA PHARMA AB Share
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Get up to date insights from finAgent about PILA PHARMA AB

Company Data

Name PILA PHARMA AB
Company Pila Pharma AB (publ)
Website https://pilapharma.com
Primary Exchange XSTO Frankfurt
WKN A3CT5N
ISIN SE0015988274
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gustav Hanghoj Gram
Market Capitalization 92 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address VAestergatan 1, 211 21 Malmö
IPO Date 2021-07-15

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB PILA.ST
Frankfurt 5KC.F
More Shares
Investors who hold PILA PHARMA AB also have the following shares in their portfolio:
CTP 25/31 MTN
CTP 25/31 MTN Bond
NATWEST MARKETS PLC FLTG RTE NTS 23/03/23
NATWEST MARKETS PLC FLTG RTE NTS 23/03/23 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025